The aim of this meta-analysis was to determine whether genetic polymorphisms in the osteoprotegerin (OPG) gene contribute to increased risk of cardiovascular disease (CVD).
Studies included in qualitative synthesis (N=9)
Full-text articles assessed for eligibility (N=90)
Studies were excluded, due to: (N=21) Letters, reviews, meta-analysis (N=30) Not human studies (N=39) Not related to research topics Additional articles identified through a manual search (N=3)
Studies were excluded, due to: (N=19) Not case-control study (N=28) Not relevant to Osteoprotegerin gene (N=34) Not relevant to cardiovascular disease 1224 reports have focused on the relation between genetic polymorphisms in OPG gene and susceptibility to CVD, especially for rs2073617 T>C and rs2073618 G>C polymorphisms [13, 21, 22] . However, the results from relevant studies were inconclusive and contradictory [23, 24] . Therefore, we performed this meta-analysis to examine the connection between OPG genetic polymorphisms and pathogenesis of CVD.
Material and Methods
Literature search and selection criteria
The Cochrane Library Database, MEDLINE, EMBASE, the Chinese Biomedical Database (CBM), and Web of Science databases were searched carefully without any language restriction.
The following keywords and MeSH terms were used: ("genetic polymorphism" or "SNP" or "variation" or "single nucleotide polymorphism" or "polymorphism" or "mutation" or "variant") and ("osteoprotegerin" or "TNFRSF11B" or "OPG" or "osteoclastogenesis inhibitory factor" or "follicular dendritic cell-derived receptor-1" or "FDCR-1 protein" or "tumor necrosis factor receptor 11b") and ("coronary artery disease" or "acute coronary syndrome" or "myocardial infarction" or "coronary arteriosclerosis" or "MI" or "CAD" or "CHD" or "ischemic heart disease" or "ACS" or "cardiovascular disease" or "CVD"). Moreover, a manual search was carried out to acquire other potential studies.
Inclusion criteria were: (1) studies focus on the relations between OPG gene polymorphism and susceptibility to CVD; (2) all patients should be diagnosed with any type of cardiovascular diseases, such as coronary artery disease (CAD), acute coronary syndrome (ACS), and ischemic heart disease (IHD); (3) the genotype frequencies of control subjects should follow Hardy-Weinberg equilibrium (HWE); (4) sufficient data about frequency of OPG polymorphisms must be provided. Articles that did not fit these inclusion criteria were eliminated. 
Data extraction
The following information from included studies was extracted by 2 authors: first author's surname, publication year, language, geographical location, subject source, study design, total number of cases, sample size, the frequency of singlenucleotide polymorphisms (SNPs), detection method of genotypes, and type of disease.
Statistical analysis
Statistical data were analyzed with STATA statistical software (Version 12.0, College Station, TX, USA). Odds ratios (OR) and corresponding 95% confidence intervals (95%CI) were estimated. The significance of pooled data and ORs were evaluated by Z test. Heterogeneity between reports was analyzed using the Cochran's Q-statistic and I 2 tests [25] . A P value <0.05 or I 2 >50% means studies were heterogeneous, in which case the random-effects model was used; otherwise, the fixed-effects model was used. Meta-regression and subgroup analyses were also applied to explore sources of heterogeneity. Sensitivity analysis was also performed. Potential publication bias was examined using Funnel plots and Egger's test [26] .
Results

Study selection and characteristics of included studies
Initially, our search strategy obtained 184 articles. We screened the titles and abstracts and then removed 90 articles. After reviewing the full texts, we excluded 81 articles. In addition, 2 studies were eliminated for lack of data integrity ( Figure 1 ). Finally, 7 clinical case-control studies that This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License enrolled 1170 CVD patients and 1194 healthy subjects were enrolled [13, 14, [22] [23] [24] 27, 28] . The publication years of enrolled studies ranged from 2004 to 2012. Overall, 5 studies were performed among Asians, and the other 2 studies were among Caucasians. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), Minisequencing, TaqMan assay, and PCR-ligase detection reaction (PCR-LDR) method were implemented for genotyping. Two genetic polymorphisms (rs2073617 T>C and rs2073618 G>C) in the OPG gene were analyzed in our meta-analysis. Genotype frequencies of controls were all in HWE (all P>0.05). The characteristics and methodological quality of enrolled studies are demonstrated in Table 1 .
Quantitative data synthesis
As presented in Figure 2 , our study showed that OPG rs2073617 T>C and rs2073618 G>C polymorphisms had statistical significance in the allele model (rs2073617 T>C: OR=1. 19 To comprehensively evaluate the influence of OPG genetic polymorphisms on the pathogenesis of CVD, we also carried out subgroup analysis based on ethnicity, disease, and genotyping method. Ethnicity-stratified subgroup analysis showed that genetic polymorphisms in the OPG gene were closely related with the development of CVD among Asians (all P<0.001; respectively) but not among Caucasians (all P>0.05) (Figure 3) . Furthermore, the results of subgroup analysis base on type of disease and genotyping method illustrated that there was a positive correlation in most subgroups. Table 2 . Meta-analysis of the relationships of opg gene with the cardiovascular disease.
OPG -osteoprotegerin; W -wild allele; M -mutant allele; WW -wild homozygote; WM -heterozygote; MM -mutant homozygote; OR -odds ratio; 95%CI -95% confidence interval; SNP -single-nucleotide polymorphisms; CAD -coronary artery disease; ACS -acute coronary syndrome; PCR-RFLP -polymerase chain reaction-restriction fragment length polymorphism.
Univariate and multivariate meta-regression analyses indicated that ethnicity may be a potential source of heterogeneity (Table 3) . Sensitivity analysis revealed the overall pooled estimates were not be influenced by any single study ( Figure 4 ). Funnel plots revealed no presence of obvious asymmetry ( Figure 5 ). No publication bias was shown in Egger's test (all P>0.05).
Discussion
Our findings showed that both rs2073617 and rs2073618 polymorphisms in the OPG gene were related with an increased risk of CVD, suggesting that OPG genetic polymorphism may be involved in the development of CVD. However, the exact mechanism of OPG genetic polymorphism in the progression of CVD Table 3 . Univariate and multivariate meta-regression analyses of potential source of heterogeneity.
SE -standard error; 95%CI -95% confidence interval; UL -upper limit; LL -lower limit; SNP -single-nucleotide polymorphisms. 1229 is still unclear. Clinically, OPG is a vital factor in bone remodeling, and in addition to its role in the skeletal system, it also is crucial in the development of inflammatory diseases and vascular disease [29, 30] . Furthermore, it is well established that the RANK/RANKL/OPG system plays an important role in many metabolic pathways and it is involved in the regulation of bone and endothelial metabolism [22] . Since OPG knockout mice concurrently exhibit arterial calcification of the great arteries, OPG has become a critical candidate gene for the development of CVD [31] . Moreover, elevated OPG concentrations have been documented to be related with the severity of unstable angina, peripheral artery disease and heart failure, vulnerable carotid plaques, symptomatic carotid stenosis, and acute myocardial infarction [32] [33] [34] . Consequently, we hypothesized that OPG genetic polymorphism, which may lead to alteration of OPG expression, might be related to the pathogenesis of CVD. The polymorphisms of T950C (rs2073617 T>C) and G1181C (rs2073618 G>C) in the OPG gene have been investigated in our meta-analysis [13, 35] . The G1181C polymorphism, located in the upstream region of exon 1, encodes the signal peptide of the OPG and causes a lysine substituted to asparagine, and the T950C polymorphism is on the promoter of OPG [36] . Sequence variations in the OPG promoter in cooperation with polymorphisms in the exon encoding for the signal peptide of this secretory protein may function synergistically in regulation of intracellular trafficking, transcription, or secretion of OPG protein [14] . Our results are consistent with a previous study that revealed that subjects with C allele in the promoter region (TC and CC) may have higher circulating levels of OPG; moreover, genetic variations in the OPG may confer an increased risk of CVD [35] . Ohmori et al. also supported that the 950TC/1181GC and 950CC/1181CC haplotypes were more prevalent in men with CAD than those without CAD [13] . Ethnicity-stratified analysis suggested that OPG polymorphism was obviously related to the development of CVD among Asians, revealing that ethnicity difference may be a causative factor influencing heterogeneity between studies. The above results demonstrate unambiguously that genetic polymorphisms in the OPG might be affected by ethnic differences closely related to the pathogenesis of CVD.
There were also some limitations which should be acknowledged. At first, owing to the small number of studies, we did not obtain all desired information from all documents. Consequently, our general findings may lack broad applicability and should be considered preliminary. Secondly, we could not obtain original data from the enrolled reports. However, 
Conclusions
In brief, our meta-analysis provided quantitative evidence that OPG genetic polymorphisms might be closely related to an increased risk of CVD, especially for rs2073617 T>C and rs2073618 G>C polymorphisms. Thus, OPG genetic polymorphisms may be considered as a potential candidate in early prediction of CVD. Nevertheless, due to several study limitations, large sample-size reports with more integral data are needed to acquire a more representative statistical analysis.
